Clinical Trials Logo

Filter by:
NCT ID: NCT00477308 Completed - HIV Infections Clinical Trials

Genotyping Directed Salvage Therapy in Children Who Have Failed Dual NRTIs

Start date: January 2006
Phase: N/A
Study type: Interventional

In HIV-NAT 013 phase I study, genotyping was performed in 95 children on dual NRTI which showed that almost all children had resistance to NRTi. The HIV-NAT 013 phase II is a follow up study to evaluate treatment outcome after salvage therapy and the evolution of mutations.

NCT ID: NCT00477126 Completed - Healthy Clinical Trials

Bioequivalence Study of Generic GPO Ritonavir Versus Norvir®

Start date: January 2007
Phase: Phase 1
Study type: Interventional

To establish bioequivalence of ritonavir generic capsule, with Norvir® as reference drug.

NCT ID: NCT00477048 Completed - Clinical trials for IDV Associated Nephrotoxicity

Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity

Start date: May 2004
Phase: Phase 2
Study type: Interventional

Efficacy and safety of a saquinavir (SQV) based regimen in HIV-1 infected Thai patients who have chronic indinavir (IDV) associated nephrotoxicity.

NCT ID: NCT00476853 Completed - HIV Infections Clinical Trials

Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy

Start date: October 2005
Phase: Phase 2
Study type: Interventional

A 48 week, randomized, open-label, two arm study to compare the efficacy, safety and tolerability of HAART containing nevirapine 400 mg/day versus nevirapine 600 mg/day in HIV-1 infected patients started at 2-6 weeks after initiating rifampicin containing antituberculosis therapy.

NCT ID: NCT00476723 Completed - HIV Clinical Trials

HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection

Start date: April 2005
Phase: Phase 3
Study type: Observational

The trial will randomise HIV/HBV co-infected individuals to different HBV-active antiretroviral therapy treatment regimens.

NCT ID: NCT00476671 Completed - HIV Infections Clinical Trials

Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1

Start date: March 2007
Phase:
Study type: Observational

To assess the prevalence and risk factors of neurocognitive impairment and psychiatric comorbidities in HIV infected patients who have undetectable viral load, have been on HAART for at least 1 year and have no history of CNS infection.

NCT ID: NCT00476606 Active, not recruiting - HIV Infections Clinical Trials

A Prospective Cohort of Children With HIV Infection

Start date: March 2003
Phase:
Study type: Observational

To evaluate clinical and immunological outcome of children treated with HAART.

NCT ID: NCT00476502 Completed - HIV Infections Clinical Trials

Study of Genetic Polymorphisms in Thai HIV-1 Infected Patients on SQV/r

Start date: February 2006
Phase: N/A
Study type: Observational

Study of genetic polymorphisms of CYP #A and MDR-1 genes in Thai HIV-1 infected patients on saquinavir/ritonavir.

NCT ID: NCT00476463 Completed - HIV Infections Clinical Trials

Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection

Start date: April 2005
Phase: Phase 2
Study type: Interventional

Combination therapy with anti-HBV activity may both increase HBV suppression rates and reduce emergence of resistant strains. Several new therapeutic agents are currently in development, however combination therapy trials in the HBV-infected population have only recently commenced. No such trials have been undertaken in the HIV/HBV co-infected population.

NCT ID: NCT00476424 Completed - HIV Infections Clinical Trials

A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects

Start date: June 2007
Phase: Phase 2
Study type: Interventional

A Pharmacokinetic study of once daily Efavirenz 400 mg versus 600 mg in Thai HIV-1 infected subjects.